Home/Omnia Medical/Chris Henneforth
CH

Chris Henneforth

Co-founder & Chief Financial Officer

Omnia Medical

Omnia Medical Pipeline

DrugIndicationPhase
PsiF DNA Sacroiliac Joint Stabilization SystemDegenerative sacroiliitis and SI joint disruptionsFDA Cleared (510(k))
PsiF Family (PsiF, PsiF90, PsiFGuard)Sacroiliac joint fusion and stabilizationCommercial
TiBrid CCervical interbody fusionCommercial
TiBrid SAStandalone anterior lumbar interbody fusionCommercial
DBLogix / CeLLogixBone graftingCommercial